Table 3 Univariate analysis for determinants of mortality after aorto-bifemoral bypasses surgery
From: Outcome and quality of life after aorto-bifemoral bypass surgery
| Â | nonsurvivors/survivors | Â | Â |
|---|---|---|---|
Variable | n = 9 n = 66 | Odds ratio (95% CI) | P |
Type of AFB surgery | Â | Â | Â |
   for Aneurysmatic disease | 4 (44)/23 (35) | 1.50 (0.36 - 6.12) | 0.575 |
   for occlusive disease | 5 (56)/43 (65) | 1 |  |
Age | 73 (67-76)/55 (62-70) | 1.15 (1.03 - 1.28) | 0.015 |
Gender | Â | - | 0.999 |
   Female | 0 (0)/2 (3) |  |  |
   Male | 9 (100)/64 (97) |  |  |
BMI, median | 20 (21-29)/24 (21-26) | 0.96 (0.74 - 1.24) | 0.733 |
Duration of anaesthesia (min.) | 333(330-450)/300 (264-357) | 1.01 (1.00 - 1.01) | 0.117 |
ASA Physical status | Â | Â | Â |
   I/II | 1 (11)/25(38) | 1 |  |
   III/IV | 8 (89)/41(62) | 4.88 (0.58 - 41.36) | 0.146 |
Temperature at admission | 34.3(34.0-35.1)/34.5(33.3-35.9) | 0.96 (0.61 - 1.50) | 0.848 |
Troponin at admission | 0.01(0.01-0.05)/0.02(0.01-0.04) | 0.001 (0 - 3500) | 0,656 |
Hypertension | 6(67)/49 (74) | 0.63 (0.16 - 3.09) | 0.631 |
Hyperlipidemia | 4 (44)/33(50) | 0.80 (0.20 - 3.25) | 0.755 |
Ischaemic heart disease | 3 (33)/29(44) | 0.64 (0.15 - 2.77) | 0.549 |
Congestive heart disease | 6 (67)/13 (20) | 8.15 (1.80 - 37.01) | 0.007 |
Cerebrovascular disease | 2 (22)/5(8) | 3.49 (0.57 - 21.45) | 0.178 |
Insulin therapy for diabetes | 0 (0)/3 (5) | - | 0.999 |
Renal insufficiency | 2 (22)/1 (2) | 18.57 (1.49 - 231.7) | 0.023 |
RCRI | Â | Â | Â |
   ≤ 2 | 1(11)/34 (52) | 1 |  |
   >2 | 8 (89)/32 (49) | 8.50 (1.01 - 71.83) | 0.049 |
Previous score in Katz scale | 0/0 | - | 0.999 |
Previous score in Lawton scale | 7 (7-7)/7(4-7) | 0.76 (0.48-1.18) | 0.215 |
SAPS II, median | 33 (19-60)/18 (13-23) | 1.09 (1.04 - 1.14) | 0.001 |
APACHE II | 13 (15-25)/8 (6-11) | 1.51 (1.17 - 1.83) | 0.001 |
Length of PACU stay (hours) | 93 (45-140)/44 (34-66) | 1.01 (1.00 - 1.02) | 0.066 |
Length of Hospital stay (days) | 9 (8-32)/11(8-27) | 1.00 (0.98 - 1.02) | 0.990 |